Clinical Trial Update: Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completed Phase 1/2 trial investigating motexafin gadolinium in combination with temozolomide and radiation therapy for newly diagnose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• Motexafin Gadolinium (motexafin gadolinium)
• Temozolomide (Temozolomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-05-17